Share Price and Basic Stock Data
Last Updated: February 3, 2026, 3:13 am
| PEG Ratio | 2.85 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Vishnu Chemicals Ltd operates within the inorganic chemicals sector, focusing on specialty chemicals. As of the latest reporting, the company recorded a market capitalization of ₹3,413 Cr and a share price of ₹507. The revenue growth trajectory has shown significant fluctuations, with annual sales rising from ₹418 Cr in March 2015 to ₹1,391 Cr in March 2023, before declining to ₹1,213 Cr in March 2024. However, the trailing twelve months (TTM) revenue improved to ₹1,512 Cr, indicating a recovery trend. Quarterly sales for September 2023 stood at ₹308 Cr, reflecting a slight decrease from ₹336 Cr in March 2023, but a recovery is observed in subsequent quarters with ₹344 Cr in September 2024. This revenue pattern suggests a cyclical business environment influenced by market demand and operational efficiencies, characteristic of the chemicals industry.
Profitability and Efficiency Metrics
The company reported a net profit of ₹138 Cr for the fiscal year ending March 2025, with a corresponding earnings per share (EPS) of ₹19.23. Profit margins remain robust, with a net profit margin of 8.75% and an operating profit margin (OPM) of 16.84%, indicating effective cost management despite revenue fluctuations. The interest coverage ratio (ICR) stood at 6.53x, illustrating sound financial health and the ability to meet interest obligations comfortably. Additionally, return on equity (ROE) was recorded at 15.5%, while return on capital employed (ROCE) was noted at 18.1%, both of which are indicative of efficient capital utilization. However, the cash conversion cycle (CCC) of 145 days raises concerns regarding liquidity and working capital management, as it is higher than typical sector ranges.
Balance Sheet Strength and Financial Ratios
Vishnu Chemicals’ balance sheet showcases a strong equity position with reserves amounting to ₹987 Cr against borrowings of ₹418 Cr, yielding a low long-term debt to equity ratio of 0.17. This indicates a conservative capital structure and lower financial risk. The book value per share has increased to ₹137.67 in March 2025, up from ₹69.37 in March 2023, reflecting retained earnings and capital preservation. However, the total debt to equity ratio of 0.36 suggests moderate leverage, which, while manageable, indicates a potential risk during economic downturns. The current ratio of 1.70 signifies good short-term liquidity, although the quick ratio at 0.88 suggests potential challenges in meeting immediate liabilities without liquidating inventory, which could pose a risk in tight liquidity situations.
Shareholding Pattern and Investor Confidence
The shareholding structure of Vishnu Chemicals indicates a strong promoter presence at 69.21%, suggesting stable management control. Foreign institutional investors (FIIs) hold 2.23% while domestic institutional investors (DIIs) account for 5.59%, reflecting cautious interest from institutional players. The number of shareholders has grown to 31,754, indicating increasing public interest in the company. However, the decline in promoter shareholding from 75% in December 2022 to the current levels may raise concerns regarding insider confidence. Public shareholding, which stands at 22.97%, highlights a diversified ownership base, but lower institutional stakes could limit price support during market volatility. This mixed sentiment could impact investor confidence going forward.
Outlook, Risks, and Final Insight
Vishnu Chemicals faces both opportunities and challenges in the evolving chemicals market. The recovery in revenues and profitability metrics suggests potential for growth, especially if operational efficiencies are optimized further. However, risks include the high cash conversion cycle, which may hinder liquidity management, and the dependence on market conditions that can be volatile. Additionally, fluctuating promoter holdings may affect investor perception and confidence. If the company can improve its operational efficiency and maintain profitability while managing its debt levels, it could enhance shareholder value significantly. Conversely, failure to address these operational challenges could lead to further declines in profitability and market position. Overall, a balanced approach focusing on strengthening operational metrics while navigating market dynamics will be crucial for sustained growth.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fischer Medical Ventures Ltd | 2,370 Cr. | 36.5 | 125/33.1 | 59.9 | 5.55 | 0.01 % | 1.08 % | 0.70 % | 1.00 |
| Emmessar Biotech & Nutrition Ltd | 13.3 Cr. | 26.7 | 42.9/24.3 | 58.0 | 16.0 | 0.00 % | 12.6 % | 4.23 % | 10.0 |
| Cochin Minerals & Rutile Ltd | 219 Cr. | 279 | 356/236 | 13.0 | 211 | 2.87 % | 23.3 % | 15.0 % | 10.0 |
| Archean Chemical Industries Ltd | 7,060 Cr. | 572 | 728/408 | 34.4 | 157 | 0.52 % | 16.0 % | 12.0 % | 2.00 |
| Alufluoride Ltd | 339 Cr. | 433 | 503/376 | 14.3 | 144 | 0.69 % | 23.6 % | 20.8 % | 10.0 |
| Industry Average | 4,706.13 Cr | 374.78 | 114.26 | 156.25 | 0.49% | 13.95% | 10.65% | 6.18 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 325 | 336 | 301 | 308 | 304 | 300 | 339 | 344 | 371 | 393 | 347 | 401 | 411 |
| Expenses | 273 | 275 | 250 | 262 | 263 | 237 | 283 | 299 | 308 | 329 | 291 | 343 | 350 |
| Operating Profit | 52 | 61 | 51 | 46 | 41 | 64 | 56 | 45 | 64 | 64 | 56 | 58 | 62 |
| OPM % | 16% | 18% | 17% | 15% | 13% | 21% | 16% | 13% | 17% | 16% | 16% | 15% | 15% |
| Other Income | 6 | 3 | 2 | 3 | 4 | 3 | 3 | 4 | 3 | 6 | 5 | 9 | 6 |
| Interest | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 8 | 8 | 12 | 14 |
| Depreciation | 7 | 7 | 7 | 9 | 9 | 9 | 9 | 9 | 12 | 8 | 10 | 10 | 11 |
| Profit before tax | 42 | 49 | 37 | 31 | 27 | 49 | 40 | 30 | 44 | 53 | 42 | 46 | 44 |
| Tax % | 25% | 27% | 23% | 22% | 23% | 43% | 24% | 25% | 23% | 27% | 23% | 28% | 23% |
| Net Profit | 32 | 36 | 29 | 24 | 21 | 28 | 30 | 23 | 34 | 39 | 32 | 33 | 34 |
| EPS in Rs | 5.32 | 5.97 | 4.79 | 3.66 | 3.17 | 4.23 | 4.65 | 3.49 | 5.25 | 5.78 | 4.79 | 4.88 | 5.02 |
Last Updated: February 3, 2026, 3:16 pm
Below is a detailed analysis of the quarterly data for Vishnu Chemicals Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 411.00 Cr.. The value appears strong and on an upward trend. It has increased from 401.00 Cr. (Sep 2025) to 411.00 Cr., marking an increase of 10.00 Cr..
- For Expenses, as of Dec 2025, the value is 350.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 343.00 Cr. (Sep 2025) to 350.00 Cr., marking an increase of 7.00 Cr..
- For Operating Profit, as of Dec 2025, the value is 62.00 Cr.. The value appears strong and on an upward trend. It has increased from 58.00 Cr. (Sep 2025) to 62.00 Cr., marking an increase of 4.00 Cr..
- For OPM %, as of Dec 2025, the value is 15.00%. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 15.00%.
- For Other Income, as of Dec 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Sep 2025) to 6.00 Cr., marking a decrease of 3.00 Cr..
- For Interest, as of Dec 2025, the value is 14.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.00 Cr. (Sep 2025) to 14.00 Cr., marking an increase of 2.00 Cr..
- For Depreciation, as of Dec 2025, the value is 11.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10.00 Cr. (Sep 2025) to 11.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Dec 2025, the value is 44.00 Cr.. The value appears to be declining and may need further review. It has decreased from 46.00 Cr. (Sep 2025) to 44.00 Cr., marking a decrease of 2.00 Cr..
- For Tax %, as of Dec 2025, the value is 23.00%. The value appears to be improving (decreasing) as expected. It has decreased from 28.00% (Sep 2025) to 23.00%, marking a decrease of 5.00%.
- For Net Profit, as of Dec 2025, the value is 34.00 Cr.. The value appears strong and on an upward trend. It has increased from 33.00 Cr. (Sep 2025) to 34.00 Cr., marking an increase of 1.00 Cr..
- For EPS in Rs, as of Dec 2025, the value is 5.02. The value appears strong and on an upward trend. It has increased from 4.88 (Sep 2025) to 5.02, marking an increase of 0.14.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:24 am
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 418 | 480 | 507 | 643 | 769 | 674 | 679 | 1,069 | 1,391 | 1,213 | 1,447 | 1,512 |
| Expenses | 339 | 396 | 441 | 562 | 667 | 591 | 600 | 911 | 1,160 | 1,010 | 1,217 | 1,270 |
| Operating Profit | 79 | 84 | 66 | 81 | 102 | 82 | 79 | 158 | 231 | 202 | 229 | 241 |
| OPM % | 19% | 18% | 13% | 13% | 13% | 12% | 12% | 15% | 17% | 17% | 16% | 16% |
| Other Income | 1 | 2 | 7 | 8 | 3 | 7 | 3 | 6 | 15 | 12 | 15 | 23 |
| Interest | 34 | 37 | 44 | 49 | 47 | 39 | 27 | 28 | 35 | 37 | 38 | 39 |
| Depreciation | 12 | 13 | 16 | 19 | 21 | 20 | 20 | 23 | 26 | 34 | 38 | 40 |
| Profit before tax | 34 | 36 | 14 | 22 | 37 | 30 | 34 | 112 | 185 | 144 | 168 | 185 |
| Tax % | 36% | 41% | 52% | 35% | 35% | 27% | -1% | 28% | 26% | 30% | 25% | |
| Net Profit | 22 | 21 | 7 | 14 | 24 | 22 | 34 | 81 | 137 | 101 | 127 | 138 |
| EPS in Rs | 3.66 | 3.56 | 1.10 | 2.42 | 4.08 | 3.72 | 5.78 | 13.63 | 22.86 | 15.43 | 18.81 | 20.70 |
| Dividend Payout % | 11% | 6% | 0% | 8% | 5% | 5% | 3% | 3% | 2% | 2% | 2% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -4.55% | -66.67% | 100.00% | 71.43% | -8.33% | 54.55% | 138.24% | 69.14% | -26.28% | 25.74% |
| Change in YoY Net Profit Growth (%) | 0.00% | -62.12% | 166.67% | -28.57% | -79.76% | 62.88% | 83.69% | -69.10% | -95.41% | 52.02% |
Vishnu Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 17% |
| 3 Years: | 11% |
| TTM: | 16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 42% |
| 3 Years: | 16% |
| TTM: | 25% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 75% |
| 3 Years: | 6% |
| 1 Year: | 19% |
| Return on Equity | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 22% |
| 3 Years: | 21% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 1:51 pm
Balance Sheet
Last Updated: December 4, 2025, 2:12 am
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 13 | 13 | 13 |
| Reserves | 79 | 106 | 85 | 99 | 130 | 148 | 184 | 265 | 402 | 688 | 913 | 987 |
| Borrowings | 225 | 263 | 322 | 381 | 348 | 328 | 336 | 365 | 379 | 315 | 342 | 418 |
| Other Liabilities | 177 | 239 | 275 | 289 | 266 | 247 | 242 | 274 | 258 | 310 | 366 | 409 |
| Total Liabilities | 492 | 620 | 694 | 782 | 757 | 736 | 773 | 916 | 1,052 | 1,326 | 1,635 | 1,827 |
| Fixed Assets | 186 | 202 | 290 | 349 | 350 | 338 | 387 | 463 | 465 | 635 | 702 | 778 |
| CWIP | 44 | 66 | 62 | 17 | 19 | 36 | 24 | 5 | 98 | 16 | 69 | 56 |
| Investments | 0 | 0 | 1 | 2 | 1 | 1 | 1 | 3 | 2 | 2 | 0 | 0 |
| Other Assets | 262 | 352 | 342 | 415 | 387 | 360 | 361 | 444 | 488 | 675 | 864 | 993 |
| Total Assets | 492 | 620 | 694 | 782 | 757 | 736 | 773 | 916 | 1,052 | 1,326 | 1,635 | 1,827 |
Below is a detailed analysis of the balance sheet data for Vishnu Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
- For Reserves, as of Sep 2025, the value is 987.00 Cr.. The value appears strong and on an upward trend. It has increased from 913.00 Cr. (Mar 2025) to 987.00 Cr., marking an increase of 74.00 Cr..
- For Borrowings, as of Sep 2025, the value is 418.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 342.00 Cr. (Mar 2025) to 418.00 Cr., marking an increase of 76.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 409.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 366.00 Cr. (Mar 2025) to 409.00 Cr., marking an increase of 43.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,827.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,635.00 Cr. (Mar 2025) to 1,827.00 Cr., marking an increase of 192.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 778.00 Cr.. The value appears strong and on an upward trend. It has increased from 702.00 Cr. (Mar 2025) to 778.00 Cr., marking an increase of 76.00 Cr..
- For CWIP, as of Sep 2025, the value is 56.00 Cr.. The value appears to be declining and may need further review. It has decreased from 69.00 Cr. (Mar 2025) to 56.00 Cr., marking a decrease of 13.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 993.00 Cr.. The value appears strong and on an upward trend. It has increased from 864.00 Cr. (Mar 2025) to 993.00 Cr., marking an increase of 129.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,827.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,635.00 Cr. (Mar 2025) to 1,827.00 Cr., marking an increase of 192.00 Cr..
Notably, the Reserves (987.00 Cr.) exceed the Borrowings (418.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -146.00 | -179.00 | -256.00 | -300.00 | -246.00 | -246.00 | -257.00 | -207.00 | -148.00 | -113.00 | -113.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 78 | 88 | 69 | 82 | 64 | 49 | 62 | 65 | 47 | 69 | 74 |
| Inventory Days | 230 | 314 | 269 | 212 | 201 | 252 | 243 | 143 | 142 | 263 | 242 |
| Days Payable | 117 | 225 | 201 | 207 | 147 | 167 | 174 | 146 | 120 | 187 | 172 |
| Cash Conversion Cycle | 191 | 176 | 137 | 87 | 117 | 134 | 131 | 63 | 69 | 145 | 145 |
| Working Capital Days | 37 | 3 | -70 | -24 | -3 | 2 | 6 | 10 | 21 | 54 | 67 |
| ROCE % | 21% | 14% | 16% | 17% | 14% | 12% | 24% | 30% | 20% | 18% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Franklin India Small Cap Fund | 1,659,420 | 0.68 | 89.69 | N/A | N/A | N/A |
| Bandhan Small Cap Fund | 956,968 | 0.27 | 51.72 | 961,765 | 2026-01-26 04:39:14 | -0.5% |
| ITI Multi Cap Fund | 298,690 | 1.2 | 16.14 | 290,199 | 2025-12-15 07:00:15 | 2.93% |
| ITI Flexi Cap Fund | 276,186 | 1.15 | 14.93 | N/A | N/A | N/A |
| Bandhan Retirement Fund | 30,083 | 0.87 | 1.63 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 19.23 | 15.90 | 22.86 | 68.13 | 28.88 |
| Diluted EPS (Rs.) | 19.23 | 15.90 | 22.86 | 68.13 | 28.88 |
| Cash EPS (Rs.) | 24.48 | 20.55 | 27.29 | 87.37 | 45.87 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 137.67 | 107.00 | 69.37 | 231.77 | 164.19 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 137.67 | 107.00 | 69.37 | 231.77 | 164.19 |
| Revenue From Operations / Share (Rs.) | 214.89 | 185.05 | 232.88 | 894.86 | 568.12 |
| PBDIT / Share (Rs.) | 36.20 | 32.66 | 41.07 | 135.12 | 67.19 |
| PBIT / Share (Rs.) | 30.53 | 27.54 | 36.63 | 115.88 | 50.20 |
| PBT / Share (Rs.) | 24.99 | 21.94 | 31.05 | 94.03 | 28.46 |
| Net Profit / Share (Rs.) | 18.81 | 15.43 | 22.86 | 68.13 | 28.88 |
| NP After MI And SOA / Share (Rs.) | 18.81 | 15.43 | 22.86 | 68.13 | 28.88 |
| PBDIT Margin (%) | 16.84 | 17.64 | 17.63 | 15.09 | 11.82 |
| PBIT Margin (%) | 14.20 | 14.88 | 15.73 | 12.94 | 8.83 |
| PBT Margin (%) | 11.62 | 11.85 | 13.33 | 10.50 | 5.01 |
| Net Profit Margin (%) | 8.75 | 8.33 | 9.81 | 7.61 | 5.08 |
| NP After MI And SOA Margin (%) | 8.75 | 8.33 | 9.81 | 7.61 | 5.08 |
| Return on Networth / Equity (%) | 13.66 | 14.41 | 32.95 | 29.39 | 17.58 |
| Return on Capital Employeed (%) | 17.99 | 19.84 | 31.99 | 25.40 | 13.47 |
| Return On Assets (%) | 7.75 | 7.62 | 12.99 | 8.89 | 4.46 |
| Long Term Debt / Equity (X) | 0.17 | 0.11 | 0.34 | 0.46 | 0.50 |
| Total Debt / Equity (X) | 0.36 | 0.34 | 0.72 | 1.04 | 1.17 |
| Asset Turnover Ratio (%) | 0.97 | 1.02 | 1.40 | 1.18 | 0.78 |
| Current Ratio (X) | 1.70 | 1.58 | 1.28 | 1.13 | 1.06 |
| Quick Ratio (X) | 0.88 | 0.81 | 0.71 | 0.67 | 0.48 |
| Inventory Turnover Ratio (X) | 4.02 | 2.69 | 3.89 | 2.86 | 1.60 |
| Dividend Payout Ratio (NP) (%) | 1.55 | 2.59 | 1.74 | 1.46 | 3.46 |
| Dividend Payout Ratio (CP) (%) | 1.19 | 1.94 | 1.46 | 1.14 | 2.18 |
| Earning Retention Ratio (%) | 98.45 | 97.41 | 98.26 | 98.54 | 96.54 |
| Cash Earning Retention Ratio (%) | 98.81 | 98.06 | 98.54 | 98.86 | 97.82 |
| Interest Coverage Ratio (X) | 6.53 | 5.83 | 7.35 | 6.19 | 3.09 |
| Interest Coverage Ratio (Post Tax) (X) | 4.40 | 3.75 | 5.09 | 4.12 | 2.33 |
| Enterprise Value (Cr.) | 3341.23 | 2341.14 | 1974.14 | 2250.42 | 636.06 |
| EV / Net Operating Revenue (X) | 2.31 | 1.93 | 1.42 | 2.11 | 0.93 |
| EV / EBITDA (X) | 13.71 | 10.94 | 8.05 | 13.94 | 7.92 |
| MarketCap / Net Operating Revenue (X) | 2.13 | 1.72 | 1.16 | 1.78 | 0.50 |
| Retention Ratios (%) | 98.44 | 97.40 | 98.25 | 98.53 | 96.53 |
| Price / BV (X) | 3.32 | 2.98 | 3.90 | 6.87 | 1.74 |
| Price / Net Operating Revenue (X) | 2.13 | 1.72 | 1.16 | 1.78 | 0.50 |
| EarningsYield | 0.04 | 0.04 | 0.08 | 0.04 | 0.10 |
After reviewing the key financial ratios for Vishnu Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 19.23. This value is within the healthy range. It has increased from 15.90 (Mar 24) to 19.23, marking an increase of 3.33.
- For Diluted EPS (Rs.), as of Mar 25, the value is 19.23. This value is within the healthy range. It has increased from 15.90 (Mar 24) to 19.23, marking an increase of 3.33.
- For Cash EPS (Rs.), as of Mar 25, the value is 24.48. This value is within the healthy range. It has increased from 20.55 (Mar 24) to 24.48, marking an increase of 3.93.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 137.67. It has increased from 107.00 (Mar 24) to 137.67, marking an increase of 30.67.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 137.67. It has increased from 107.00 (Mar 24) to 137.67, marking an increase of 30.67.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 214.89. It has increased from 185.05 (Mar 24) to 214.89, marking an increase of 29.84.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 36.20. This value is within the healthy range. It has increased from 32.66 (Mar 24) to 36.20, marking an increase of 3.54.
- For PBIT / Share (Rs.), as of Mar 25, the value is 30.53. This value is within the healthy range. It has increased from 27.54 (Mar 24) to 30.53, marking an increase of 2.99.
- For PBT / Share (Rs.), as of Mar 25, the value is 24.99. This value is within the healthy range. It has increased from 21.94 (Mar 24) to 24.99, marking an increase of 3.05.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 18.81. This value is within the healthy range. It has increased from 15.43 (Mar 24) to 18.81, marking an increase of 3.38.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 18.81. This value is within the healthy range. It has increased from 15.43 (Mar 24) to 18.81, marking an increase of 3.38.
- For PBDIT Margin (%), as of Mar 25, the value is 16.84. This value is within the healthy range. It has decreased from 17.64 (Mar 24) to 16.84, marking a decrease of 0.80.
- For PBIT Margin (%), as of Mar 25, the value is 14.20. This value is within the healthy range. It has decreased from 14.88 (Mar 24) to 14.20, marking a decrease of 0.68.
- For PBT Margin (%), as of Mar 25, the value is 11.62. This value is within the healthy range. It has decreased from 11.85 (Mar 24) to 11.62, marking a decrease of 0.23.
- For Net Profit Margin (%), as of Mar 25, the value is 8.75. This value is within the healthy range. It has increased from 8.33 (Mar 24) to 8.75, marking an increase of 0.42.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.75. This value is within the healthy range. It has increased from 8.33 (Mar 24) to 8.75, marking an increase of 0.42.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.66. This value is below the healthy minimum of 15. It has decreased from 14.41 (Mar 24) to 13.66, marking a decrease of 0.75.
- For Return on Capital Employeed (%), as of Mar 25, the value is 17.99. This value is within the healthy range. It has decreased from 19.84 (Mar 24) to 17.99, marking a decrease of 1.85.
- For Return On Assets (%), as of Mar 25, the value is 7.75. This value is within the healthy range. It has increased from 7.62 (Mar 24) to 7.75, marking an increase of 0.13.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.17. This value is below the healthy minimum of 0.2. It has increased from 0.11 (Mar 24) to 0.17, marking an increase of 0.06.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.36. This value is within the healthy range. It has increased from 0.34 (Mar 24) to 0.36, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.97. It has decreased from 1.02 (Mar 24) to 0.97, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.70. This value is within the healthy range. It has increased from 1.58 (Mar 24) to 1.70, marking an increase of 0.12.
- For Quick Ratio (X), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 1. It has increased from 0.81 (Mar 24) to 0.88, marking an increase of 0.07.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.02. This value is within the healthy range. It has increased from 2.69 (Mar 24) to 4.02, marking an increase of 1.33.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 1.55. This value is below the healthy minimum of 20. It has decreased from 2.59 (Mar 24) to 1.55, marking a decrease of 1.04.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 20. It has decreased from 1.94 (Mar 24) to 1.19, marking a decrease of 0.75.
- For Earning Retention Ratio (%), as of Mar 25, the value is 98.45. This value exceeds the healthy maximum of 70. It has increased from 97.41 (Mar 24) to 98.45, marking an increase of 1.04.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 98.81. This value exceeds the healthy maximum of 70. It has increased from 98.06 (Mar 24) to 98.81, marking an increase of 0.75.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.53. This value is within the healthy range. It has increased from 5.83 (Mar 24) to 6.53, marking an increase of 0.70.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.40. This value is within the healthy range. It has increased from 3.75 (Mar 24) to 4.40, marking an increase of 0.65.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,341.23. It has increased from 2,341.14 (Mar 24) to 3,341.23, marking an increase of 1,000.09.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.31. This value is within the healthy range. It has increased from 1.93 (Mar 24) to 2.31, marking an increase of 0.38.
- For EV / EBITDA (X), as of Mar 25, the value is 13.71. This value is within the healthy range. It has increased from 10.94 (Mar 24) to 13.71, marking an increase of 2.77.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.13. This value is within the healthy range. It has increased from 1.72 (Mar 24) to 2.13, marking an increase of 0.41.
- For Retention Ratios (%), as of Mar 25, the value is 98.44. This value exceeds the healthy maximum of 70. It has increased from 97.40 (Mar 24) to 98.44, marking an increase of 1.04.
- For Price / BV (X), as of Mar 25, the value is 3.32. This value exceeds the healthy maximum of 3. It has increased from 2.98 (Mar 24) to 3.32, marking an increase of 0.34.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.13. This value is within the healthy range. It has increased from 1.72 (Mar 24) to 2.13, marking an increase of 0.41.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Vishnu Chemicals Ltd:
- Net Profit Margin: 8.75%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 17.99% (Industry Average ROCE: 13.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.66% (Industry Average ROE: 10.65%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.4
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.88
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 24.8 (Industry average Stock P/E: 114.26)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.36
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8.75%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Others | Plot No. C-23, Road No. 8, Film Nagar, Jubilee Hills, Hyderabad Telangana 500096 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Cherukuri Krishna Murthy | Chairman & Managing Director |
| Mr. Cherukuri Siddartha | Joint Managing Director |
| Mrs. Cherukuri Manjula | Non Executive Director |
| Mr. Tirthankar Mitra | Independent Director |
| Mr. Naga Bhushan Bhagwat | Independent Director |
| Mr. Veeramachaneni Vimalanand | Independent Director |
| Dr. Sita Vanka | Independent Director |
FAQ
What is the intrinsic value of Vishnu Chemicals Ltd?
Vishnu Chemicals Ltd's intrinsic value (as of 03 February 2026) is ₹498.44 which is 1.88% lower the current market price of ₹508.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹3,423 Cr. market cap, FY2025-2026 high/low of ₹596/336, reserves of ₹987 Cr, and liabilities of ₹1,827 Cr.
What is the Market Cap of Vishnu Chemicals Ltd?
The Market Cap of Vishnu Chemicals Ltd is 3,423 Cr..
What is the current Stock Price of Vishnu Chemicals Ltd as on 03 February 2026?
The current stock price of Vishnu Chemicals Ltd as on 03 February 2026 is ₹508.
What is the High / Low of Vishnu Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Vishnu Chemicals Ltd stocks is ₹596/336.
What is the Stock P/E of Vishnu Chemicals Ltd?
The Stock P/E of Vishnu Chemicals Ltd is 24.8.
What is the Book Value of Vishnu Chemicals Ltd?
The Book Value of Vishnu Chemicals Ltd is 149.
What is the Dividend Yield of Vishnu Chemicals Ltd?
The Dividend Yield of Vishnu Chemicals Ltd is 0.06 %.
What is the ROCE of Vishnu Chemicals Ltd?
The ROCE of Vishnu Chemicals Ltd is 18.1 %.
What is the ROE of Vishnu Chemicals Ltd?
The ROE of Vishnu Chemicals Ltd is 15.5 %.
What is the Face Value of Vishnu Chemicals Ltd?
The Face Value of Vishnu Chemicals Ltd is 2.00.